US Tech 100

20,897.20

-1.35%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
Interleukin Genetics, (ILI)
Interleukin Genetics, (ILI) News

ILI

Interleukin Genetics (ILI)

Interleukin Genetics,

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:ILI

1 2 3 4 5 6 7 Next >>

Date	Time	Source	Headline	Symbol	Company
08/12/2010	4:07PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ILI	Interleukin Genetics,
08/05/2010	4:01PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:ILI	Interleukin Genetics,
08/05/2010	8:49AM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:ILI	Interleukin Genetics,
08/05/2010	7:02AM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
07/21/2010	4:30PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
06/25/2010	5:06PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
06/21/2010	6:31AM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
05/13/2010	4:06PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ILI	Interleukin Genetics,
05/05/2010	6:02AM	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILI	Interleukin Genetics,
04/30/2010	7:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
04/30/2010	7:06PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:ILI	Interleukin Genetics,
04/30/2010	4:36PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
04/30/2010	1:15PM	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	AMEX:ILI	Interleukin Genetics,
04/13/2010	5:04PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	AMEX:ILI	Interleukin Genetics,
04/08/2010	4:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
04/08/2010	4:24PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
04/05/2010	4:35PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	AMEX:ILI	Interleukin Genetics,
04/01/2010	4:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
03/25/2010	4:13PM	Edgar (US Regulatory)	Annual Report (10-K)	AMEX:ILI	Interleukin Genetics,
03/19/2010	4:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
03/10/2010	5:11PM	Edgar (US Regulatory)	Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)	AMEX:ILI	Interleukin Genetics,
03/09/2010	9:46AM	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	AMEX:ILI	Interleukin Genetics,
03/05/2010	2:52PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(5) (424B5)	AMEX:ILI	Interleukin Genetics,
03/03/2010	2:04PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
03/01/2010	5:00PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
02/19/2010	5:03PM	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	AMEX:ILI	Interleukin Genetics,
02/04/2010	7:00AM	PR Newswire (US)	Interleukin Genetics to Present at the 12th Annual BIO CEO Conference	AMEX:ILI
02/03/2010	4:34PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:ILI	Interleukin Genetics,
02/02/2010	5:01PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
01/25/2010	4:17PM	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,